Yes, it was stopped abruptly. If it wasn't describ
Post# of 72440
But it doesn't necessarily mean the drug has problem, that's not what I'm inferring. So, stop putting words into my mouth. The plausible explanation is that a certain big pharma probably want to see some evidence of P53 modulation by Kevetrin in ovarian cancer trial. IPIX probably got some evidence on a patient (see the presentation slides), the big pharma was satisfied with it, so they stopped the trial since they're also short of money, end of story. Is this soft-bashing as well?
Being bull doesn't mean pumping irregardless. There are people out there who wants to read both the positive and negative sides of this company, the middle ground.
Yes, a lot of retail investors are worried because they saw their wealth decimated by the collapse of IPIX share price. This is a fact. I would be very surprise if you tell me that you're perfectly happy with your IPIX holdings that have gone down so much over the years.